NCT02971930View on ClinicalTrials.gov

Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A

CompletedOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

June 20, 2017

Primary Completion Date

November 26, 2017

Study Completion Date

December 15, 2017

Conditions

Hemophilia A

Interventions

BIOLOGICAL

BAY94-9027

Intravenous infusion of BAY94-9027

Trial Locations (1)

110605

Cleveland, Cleveland

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY